⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Oxytocin
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-08-28 — Identifying novel druggable targets and repurposable drugs for premature ovarian insufficiency by integrated multiomics and causal inference analysis.: cross-connection with poi-repurposable-targets: OXT (oxytocin) appears among the seven MR-prioritized causal proteins for POI, linking the ovarian-aging target set to the existing oxytocin page. (novelty: 3)
- 2026-06-26 — Hormonal dimorphism in sarcopenia disease.: Narrative review (no new primary data) positions oxytocin-mediated muscle regeneration as compromised by estrogen decline, proposing oxytocin modulation as a female-skewed sarcopenia strategy. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Hormonal dimorphism in sarcopenia disease.
26-jun-2026
novelty 3
per-area 3
strengthens